The Course of General Cognitive Ability in Individuals With Psychotic Disorders
- PMID: 35583896
- PMCID: PMC9118026
- DOI: 10.1001/jamapsychiatry.2022.1142
The Course of General Cognitive Ability in Individuals With Psychotic Disorders
Abstract
Importance: Schizophrenia is associated with major cognitive deficits and has been conceptualized as both a neurodevelopmental and a neurodegenerative disorder. However, when deficits develop and how they change over the course of illness is uncertain.
Objective: To trace cognition from elementary school to old age to test neurodevelopmental and neurodegenerative theories of psychotic disorders.
Design, setting, and participants: Data were taken from the Suffolk County Mental Health Project, a first-admission longitudinal cohort study of individuals with psychotic disorders. Participants were recruited from all 12 inpatient psychiatric facilities in Suffolk County, New York. This analysis concerns the 428 participants with at least 2 estimates of general cognitive ability. Data were collected between September 1989 and October 2019, and data were analyzed from January 2020 to October 2021.
Exposures: Psychiatric hospitalization for psychosis.
Main outcomes and measures: Preadmission cognitive scores were extracted from school and medical records. Postonset cognitive scores were based on neuropsychological testing at 6-month, 24-month, 20-year, and 25-year follow-ups.
Results: Of the 428 included individuals (212 with schizophrenia and 216 with other psychotic disorders), 254 (59.6%) were male, and the mean (SD) age at psychosis onset was 27 (9) years. Three phases of cognitive change were observed: normative, declining, and deteriorating. In the first phase, cognition was stable. Fourteen years before psychosis onset, those with schizophrenia began to experience cognitive decline at a rate of 0.35 intelligence quotient (IQ) points per year (95% CI, 0.29-0.42; P < .001), a significantly faster decline than those with other psychotic disorders (0.15 IQ points per year; 95% CI, 0.08-0.22, P < .001). At 22 years after onset, both groups declined at a rate of 0.59 IQ points per year (95% CI, 0.25-0.94; P < .001).
Conclusions and relevance: In this cohort study, cognitive trajectories in schizophrenia were consistent with both a neurodevelopmental and neurodegenerative pattern, resulting in a loss of 16 IQ points over the period of observation. Cognitive decline began long prior to psychosis onset, suggesting the window for primary prevention is earlier than previously thought. A window for secondary prevention emerges in the third decade of illness, when cognitive declines accelerate in individuals with schizophrenia and other psychotic disorders.
Conflict of interest statement
Figures



Similar articles
-
Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders: Findings From the Suffolk County Mental Health Project.JAMA Psychiatry. 2020 Apr 1;77(4):387-396. doi: 10.1001/jamapsychiatry.2019.3993. JAMA Psychiatry. 2020. PMID: 31825511 Free PMC article.
-
Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.JAMA Psychiatry. 2015 Apr;72(4):377-85. doi: 10.1001/jamapsychiatry.2014.2671. JAMA Psychiatry. 2015. PMID: 25715178 Free PMC article.
-
Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project.Am J Psychiatry. 2017 Nov 1;174(11):1064-1074. doi: 10.1176/appi.ajp.2017.16101191. Epub 2017 Aug 4. Am J Psychiatry. 2017. PMID: 28774193 Free PMC article.
-
Cognitive trajectories following onset of psychosis: a meta-analysis.Br J Psychiatry. 2022 Dec;221(6):714-721. doi: 10.1192/bjp.2022.131. Br J Psychiatry. 2022. PMID: 36149012 Review.
-
Cognitive development prior to onset of psychosis.Psychol Med. 2018 Feb;48(3):392-403. doi: 10.1017/S0033291717001970. Epub 2017 Jul 24. Psychol Med. 2018. PMID: 28735586 Review.
Cited by
-
Use of the Chinese version of the MATRICS Consensus Cognitive Battery to assess cognitive functioning in individuals with high risk for psychosis, first-episode schizophrenia and chronic schizophrenia: a systematic review and meta-analysis.Lancet Reg Health West Pac. 2024 Feb 9;45:101016. doi: 10.1016/j.lanwpc.2024.101016. eCollection 2024 Apr. Lancet Reg Health West Pac. 2024. PMID: 38699289 Free PMC article. Review.
-
20-year neurocognitive development following a schizophrenia spectrum disorder and associations with symptom severity and functional outcomes.Psychol Med. 2024 Jul;54(9):2004-2014. doi: 10.1017/S0033291724000096. Epub 2024 Feb 12. Psychol Med. 2024. PMID: 38343378 Free PMC article.
-
Association Between Neighborhood Deprivation and Child Cognition in Clinically Referred Youth.J Dev Behav Pediatr. 2023 Oct-Nov 01;44(8):e543-e550. doi: 10.1097/DBP.0000000000001210. Epub 2023 Aug 18. J Dev Behav Pediatr. 2023. PMID: 37590215 Free PMC article.
-
Cognitive Effects of Reducing First-Generation Antipsychotic Dose Compared to Switching to Ziprasidone in Long-Stay Patients with Schizophrenia.J Clin Med. 2024 Apr 4;13(7):2112. doi: 10.3390/jcm13072112. J Clin Med. 2024. PMID: 38610877 Free PMC article.
-
Specific immune-inflammatory profiles and neurocognitive deficits predict illness trajectories in people with type 2 diabetes mellitus or psychiatric disorders.Brain Behav Immun Health. 2025 Feb 13;44:100962. doi: 10.1016/j.bbih.2025.100962. eCollection 2025 Mar. Brain Behav Immun Health. 2025. PMID: 40046177 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical